Practice
Featured experience
GSK collaboration with Flagship Pioneering
We are advising GSK on the transaction
Azul $800 million secured notes offering
The senior secured notes are due 2028
Kenvue $4.37 billion IPO
The carve-out of the former Johnson & Johnson consumer health business is the largest U.S. IPO since November 2021
NBCUniversal partnership with MultiChoice to relaunch Showmax using Peacock
We are advising NBCUniversal on the transaction to relaunch MultiChoice’s Showmax service using the Peacock platform
Immunocore $297 million IPO
We advised the joint book-running managers and underwriters on the IPO and Nasdaq listing
Terns Pharmaceuticals $127.5 million IPO
We advised the underwriters on the IPO and Nasdaq listing
RTL Group $1.17 billion sale of SpotX to Magnite
We are advising RTL Group on the sale of its U.S. ad-tech company
23andMe $3.5 billion merger with Virgin Group’s VG Acquisition
We are advising a SPAC on its merger with 23andMe
Shiseido transfer of Personal Care business to CVC
We are advising Shiseido on the transaction, which will involve the formation of a new joint venture between Shiseido and CVC
Home Point Capital $94 million IPO
We advised the underwriters on the IPO and Nasdaq listing
PLAYSTUDIOS business combination with Acies Acquisition
We are advising PLAYSTUDIOS on its combination with Acies, a SPAC
Shoals Technologies Group $2.2 billion IPO
The shares are listed on the Nasdaq Global Market
TPG Capital acquisition of a majority stake in Centrify
We are advising TPG Capital on its acquisition of a majority stake in Centrify from Thoma Bravo
Playtika Holding $2 billion IPO
The shares are listed on the Nasdaq Global Select Market